approval · primary record
TRABECTEDIN
3 approval events · latest 2026-10-01
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Latest action | 2026-10-01 |
| Approval events | 3 |
| Brand | TRABECTEDIN |
| Sponsor | EVER |
| Route | INTRAVENOUS |
Approval history
3 actions on record. The drug is the stable record; each action below is an event with its own date, so this URL keeps working as new actions arrive.
| Date | Agency | Type | Brand | Sponsor | Route |
|---|---|---|---|---|---|
| 2026-10-01 | FDA | NDA | TRABECTEDIN | EVER | INTRAVENOUS |
| 2026-05-01 | FDA | NDA | EVDI | APOTEX | INTRAVENOUS |
| 2025-12-23 | FDA | NDA | YONDELIS | JANSSEN PRODS | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-30T00:27:52.928Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: approval:trabectedin
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Trabectedin · compound